Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast

[1]  Marta Cuadros,et al.  Systematic Review of HER2 Breast Cancer Testing , 2009, Applied immunohistochemistry & molecular morphology : AIMM.

[2]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[3]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[4]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[5]  G. Semenza,et al.  Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.

[6]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Nirmala Ramanujam,et al.  Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. , 2009, Cancer research.

[8]  Peter J. Ell,et al.  18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Takashi Kusaka,et al.  Developmental Changes of Optical Properties in Neonates Determined by Near-Infrared Time-Resolved Spectroscopy , 2005, Pediatric Research.

[10]  David A Boas,et al.  Assessing the future of diffuse optical imaging technologies for breast cancer management. , 2008, Medical physics.

[11]  Mamoru Tamura,et al.  Clinical evaluation of time-resolved spectroscopy by measuring cerebral hemodynamics during cardiopulmonary bypass surgery. , 2007, Journal of biomedical optics.

[12]  F. Diekmann,et al.  Diagnostic performance of a near-infrared breast imaging system as adjunct to mammography versus X-ray mammography alone , 2012, European Radiology.

[13]  T. Suzuki,et al.  Time-Resolved Optical Mammography and Its Preliminary Clinical Results , 2011, Technology in cancer research & treatment.

[14]  Dai Fukumura,et al.  Normalization of the tumor vasculature through oncogenic inhibition: An emerging paradigm in tumor biology , 2012, Proceedings of the National Academy of Sciences.

[15]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[16]  B. Wilson,et al.  Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. , 1989, Applied optics.

[17]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[18]  B. Tromberg,et al.  In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. , 2006, Journal of biomedical optics.

[19]  Sergio Fantini,et al.  Near-Infrared Optical Mammography for Breast Cancer Detection with Intrinsic Contrast , 2011, Annals of Biomedical Engineering.

[20]  Quing Zhu,et al.  Optimal Probing of Optical Contrast of Breast Lesions of Different Size Located at Different Depths by US Localization , 2006, Technology in cancer research & treatment.

[21]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[22]  W. Yang.  Emerging techniques and molecular imaging in breast cancer. , 2011, Seminars in ultrasound, CT, and MR.

[23]  David Hsiang,et al.  Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study. , 2009, Journal of biomedical optics.

[24]  N. Fujiuchi,et al.  Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response , 2012 .

[25]  H. Matsuda,et al.  Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma , 2008, Annals of nuclear medicine.

[26]  G. Semenza.  HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.

[27]  I. Ellis,et al.  Expert Commentary. , 2002, Histopathology.

[28]  B. Tromberg,et al.  Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy , 2005, Breast Cancer Research.

[29]  E. Cronin,et al.  Early-stage invasive breast cancers: potential role of optical tomography with US localization in assisting diagnosis. , 2010, Radiology.

[30]  S. Fox,et al.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes , 1997, Cancer research.

[31]  R. Shaw,et al.  Glucose metabolism and cancer. , 2006, Current opinion in cell biology.

[32]  H. Tsuda,et al.  Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin‐like growth factor receptor type 1 , 2006, Cancer science.

[33]  C. Shimizu,et al.  Immunohistochemical evaluation for hormone receptors in Breast Cancer: A practically useful evaluation system and handling protocol , 2006, Breast cancer.

[34]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[35]  S. Larson.  Positron Emission Tomography-Based Molecular Imaging in Human Cancer , 2004, Clinical Cancer Research.